Shaping the future of clinical trials in the EU
Later this month, experts from healthcare companies, contract research organisations (CROs), and patient advocacy groups will gather to do a…
Featured
-
-
Can AI replace medical writers? Experts say not immediately
AI is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but those using…
-
Saving shelved ultra-rare therapies through unorthodox funding
As a funding drought for biopharma is on the horizon, non-profit biotech Orphan Therapeutics Accelerator is championing an innovative funding…
-
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply
The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial…
-
Are European biopharma manufacturers ‘nearshoring’?
In step with international news in recent times, European pharma and biotech are leaning towards ‘nearshoring’, preferring domestic operations to…
-
Machine learning adoption into supply chain management on the horizon
Widespread integration of machine learning (ML) into supply chain management by major pharma suppliers is just a few years away,…
-
Inborn errors of metabolism elicit unique challenges for therapy development
In recent years, major progress has been made in the development of gene therapies for rare diseases. However, research for…
-
New EU trial regulations could expedite approvals and address shortages
A major overhaul and consolidation of EU clinical trial regulations is paving the way to faster approvals, greater international coordination,…
-
Mandatory drug stock monitoring empowers EU to tackle shortages
Earlier this month, the newly empowered role of the European Union (EU)’s Executive Steering Group on Shortages and Safety of…
-
Supply chains and AI take precedence at European clinical trial meeting
As global supply chains come under increasing strain and AI disrupts how clinical trials are conducted, experts will congregate to…
